Neuralink is the creator of a brain-machine interface that can be implanted, specifically designed to aid individuals with paralysis. The company's interface is engineered not only to diagnose and treat human neurological disorders but also to potentially enhance human cognitive abilities. This innovation allows physicians to effectively address severe brain conditions in the short term.

Investors Include:

Blake Byers, GigaFund, Sam Altman, Calm Ventures, Ken Howery, EXOR Seeds, Valor Equity Partners, Alphabet, Time BioVentures, IPO Club, Raison, MicroVentures, Founders Fund, Oak Grove Ventures, Capital Advantage Ventures, Shake and Bake, Vy Capital, Robert Nelson, Type One Ventures, Humla Ventures, Redefine Ventures, Fred Ehrsam, East River Venture Partners, S32, MarketX.

Own Neuralink stock or options?

Get an instant valuation

Completely free
100% confidential & secure
Takes less than a minute

What company do you own stock or options in?

How many shares or options do you own?

100% private & secure

Our available services for this company

Lifetime IncomeCharitable Remainder Trust

Tax SavingsDonor Advised Fund